3D Kinematic Assessment of the Human Knee During Physical and Daily Life Activities

NCT ID: NCT01661647

Last Updated: 2024-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-02

Study Completion Date

2026-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Problem : Precise and personalized 3D knee kinematic assessment during physical and daily life activities is a challenge; therefore, it was never performed on an important number of individuals. However, a better understanding of 3D knee kinematics during such activities would allow a better understanding of this often injured joint.

Hypothesis: A new system using personalized 3D bone imaging and a percutaneous bone fixation device that can be used under local anesthesiaallows for precise and reproducible assessment of 3D knee kinematics during physical and daily life activities.

Objectives :

* To study human knee 3D kinematics during dynamic activities using a novel minimally invasive measuring system
* Investigate the correlations between standard clinical knee laxity tests and measured 3D knee kinematics during dynamic activities

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

3D Knee Kinematics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

3D knee kinematic assessment

3D knee kinematic assessment under local anesthesia

Group Type EXPERIMENTAL

3D knee kinematic assessment under local anesthesia

Intervention Type DEVICE

3D knee kinematic assessment under local anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

3D knee kinematic assessment under local anesthesia

3D knee kinematic assessment under local anesthesia

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients awaiting knee arthroscopy under local anesthesia for a medial meniscal tear

Exclusion Criteria

* Active infection
* Severe swelling of the knee
* Knee flexion contracture
* Knee flexion less than 120 degrees
* Gross limping
* Inability to perform the various motor tasks required by the study protocol
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eiffel Medtech

INDUSTRY

Sponsor Role collaborator

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Frédéric Lavoie, MD MSc FRCSC

Role: PRINCIPAL_INVESTIGATOR

CHUM

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHUM

Montreal, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Frédéric Lavoie, MD MSc FRCSC

Role: CONTACT

1-514-890-8000 ext. 25900

Fidaa Al-Shakfa, MSc

Role: CONTACT

1-514-890-8000 ext. 26103

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Frédéric Lavoie, MD MSc FRCSC

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CE 12.005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The 3DKnee™ System: A Post-Market Study
NCT00764673 COMPLETED PHASE4